• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

20岁后自我报告的体重增加与脂肪性肝病风险

Self-Reported Weight Gain After the Age of 20 and Risk of Steatotic Liver Disease.

作者信息

Iwasa Masayo, Ozu Naoki, Yamakage Hajime, Kato Hisashi, Ishikawa Misato, Kanasaki Megumi, Masuda Izuru, Tanaka Masashi, Satoh-Asahara Noriko

机构信息

Department of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute, NHO Kyoto Medical Center, 1-1 Fukakusa Mukaihata-cho, Fushimi-ku, Kyoto 612-8555, Japan.

Institute for Clinical and Translational Science, Nara Medical University Hospital, Kashihara 634-8522, Japan.

出版信息

Nutrients. 2025 Aug 6;17(15):2566. doi: 10.3390/nu17152566.

DOI:10.3390/nu17152566
PMID:40806150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12348315/
Abstract

: We aimed to identify questionnaire items associated with an increased risk of developing hepatic steatosis in the general population. : A total of 15,063 individuals aged ≥20 years who underwent general health checkups and had no hepatic steatosis at baseline were included. The relationship between questionnaire data at baseline and hepatic steatosis incidence over a median 4.2-year follow-up was investigated across body mass index (BMI) categories. : Among 15,063 individuals (mean [SD] age, 47.1 [10.2] years; 6769 [44.9%] male; mean [SD] BMI, 21.4 [2.6] kg/m), 1889 individuals (12.5%) developed hepatic steatosis during follow-up. After adjusting for age, sex, and factors related to metabolic diseases and liver injury, the strongest questionnaire-based risk factor for hepatic steatosis was self-reported weight gain of 10 kg or more after the age of 20 across all BMI categories: total population (hazard ratio [HR], 2.11; 95% confidence interval [CI], 1.90-2.34; < 0.001), Category 1 (BMI < 22) (HR, 2.33; 95% CI, 1.86-2.91; < 0.001), Category 2 (BMI 22 to <25) (HR, 1.43; 95% CI, 1.25-1.63; < 0.001), and Category 3 (BMI ≥ 25) (HR, 1.41; 95% CI, 1.12-1.77; = 0.003). : In this cohort study, self-reported weight gain of 10 kg or more after the age of 20 was associated with an increased risk of hepatic steatosis, independent of baseline BMI. Questionnaires capturing weight gain history may support universal screening efforts to identify individuals at elevated risk.

摘要

我们旨在确定与普通人群发生肝脂肪变性风险增加相关的问卷项目。纳入了总共15063名年龄≥20岁且在基线时无肝脂肪变性的接受一般健康检查的个体。在不同体重指数(BMI)类别中,研究了基线时的问卷数据与中位4.2年随访期间肝脂肪变性发生率之间的关系。在15063名个体(平均[标准差]年龄,47.1[10.2]岁;6769名[44.9%]男性;平均[标准差]BMI,21.4[2.6]kg/m²)中,1889名个体(12.5%)在随访期间发生了肝脂肪变性。在调整年龄、性别以及与代谢疾病和肝损伤相关的因素后,在所有BMI类别中,基于问卷的肝脂肪变性最强风险因素是自我报告的20岁后体重增加10千克或更多:总体人群(风险比[HR],2.11;95%置信区间[CI],1.90 - 2.34;P < 0.001),第1类(BMI < 22)(HR,2.33;95%CI,1.86 - 2.91;P < 0.001),第2类(BMI 22至<25)(HR,1.43;95%CI,1.25 - 1.63;P < 0.001),以及第3类(BMI≥25)(HR,1.41;95%CI,1.12 - 1.77;P = 0.003)。在这项队列研究中,自我报告的20岁后体重增加10千克或更多与肝脂肪变性风险增加相关,独立于基线BMI。记录体重增加历史的问卷可能有助于识别高风险个体的普遍筛查工作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9db4/12348315/e736340af526/nutrients-17-02566-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9db4/12348315/4e66afa10d65/nutrients-17-02566-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9db4/12348315/e736340af526/nutrients-17-02566-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9db4/12348315/4e66afa10d65/nutrients-17-02566-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9db4/12348315/e736340af526/nutrients-17-02566-g002.jpg

相似文献

1
Self-Reported Weight Gain After the Age of 20 and Risk of Steatotic Liver Disease.20岁后自我报告的体重增加与脂肪性肝病风险
Nutrients. 2025 Aug 6;17(15):2566. doi: 10.3390/nu17152566.
2
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.孕期超重或肥胖女性使用二甲双胍以改善母婴结局。
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
3
Are There Sex Differences in the Association of Alcohol Consumption With the Risk of Soft Tissue Sarcoma? A Nationwide Population-based Study in Korea.饮酒与软组织肉瘤风险之间的关联存在性别差异吗?韩国一项基于全国人口的研究。
Clin Orthop Relat Res. 2025 Jun 25. doi: 10.1097/CORR.0000000000003602.
4
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
5
[Association between obesity and the risk of microvascular complications in Yinzhou District, Ningbo adults with type 2 diabetes mellitus].[宁波鄞州区2型糖尿病成年患者肥胖与微血管并发症风险的相关性]
Wei Sheng Yan Jiu. 2025 Jul;54(4):608-620. doi: 10.19813/j.cnki.weishengyanjiu.2025.04.012.
6
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
7
Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India.成人肺结核患者的营养支持:在印度恰尔康得邦 RATIONS 试验中的一个方案性队列中的结局。
Lancet Glob Health. 2023 Sep;11(9):e1402-e1411. doi: 10.1016/S2214-109X(23)00324-8. Epub 2023 Aug 8.
8
Interventions for preventing weight gain after smoking cessation.戒烟后预防体重增加的干预措施。
Cochrane Database Syst Rev. 2012 Jan 18;1:CD006219. doi: 10.1002/14651858.CD006219.pub3.
9
Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson's Disease.体重指数变化与帕金森病全因死亡率的关系。
J Parkinsons Dis. 2024;14(7):1441-1450. doi: 10.3233/JPD-240181.
10
Prevalence, Incidence, and Recovery of Metabolic Dysfunction-associated Steatotic Liver Disease and Associations With Weight Loss and Lipid Reduction in a Chinese Community-based Cohort.中国社区队列中代谢功能障碍相关脂肪性肝病的患病率、发病率、康复情况及其与体重减轻和血脂降低的关联
J Epidemiol. 2025 Apr 5;35(4):195-205. doi: 10.2188/jea.JE20240224. Epub 2025 Feb 28.

本文引用的文献

1
Culturally tailored steatotic liver disease management: Latino and Asian community partner perspectives and recommendations.文化定制化的脂肪性肝病管理:拉丁裔和亚裔社区合作伙伴的观点与建议。
Hepatol Commun. 2025 Jun 9;9(7). doi: 10.1097/HC9.0000000000000749. eCollection 2025 Jul 1.
2
Steatotic liver disease.脂肪变性肝疾病。
Lancet. 2024 Nov 2;404(10464):1761-1778. doi: 10.1016/S0140-6736(24)01811-7.
3
Does Breast Feeding Protect Mothers From Obesity?母乳喂养能保护母亲免于肥胖吗?
Cureus. 2024 Sep 25;16(9):e70217. doi: 10.7759/cureus.70217. eCollection 2024 Sep.
4
Potential Drawbacks of Noninvasive Diagnostic Methods for Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病无创性诊断方法的潜在缺陷。
J Am Board Fam Med. 2024 Jul-Aug;37(4):753-772. doi: 10.3122/jabfm.2023.230005R2.
5
Transforming steatotic liver disease management: The emerging role of GLP-1 receptor agonists.转化肝脂肪变性疾病管理:GLP-1 受体激动剂的新兴作用。
Hepatol Commun. 2024 Oct 10;8(11). doi: 10.1097/HC9.0000000000000561. eCollection 2024 Nov 1.
6
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review.代谢功能障碍相关脂肪性肝病与心血管风险:全面综述。
Cardiovasc Diabetol. 2024 Sep 28;23(1):346. doi: 10.1186/s12933-024-02434-5.
7
Associations of traditional healthy lifestyle and sleep quality with metabolic dysfunction-associated fatty liver disease: two population-based studies.传统健康生活方式和睡眠质量与代谢相关脂肪性肝病的关联:两项基于人群的研究。
Nutr Diabetes. 2024 Sep 27;14(1):79. doi: 10.1038/s41387-024-00339-6.
8
A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病生活方式管理指南的叙述性综述
Hepatology. 2024 Aug 15. doi: 10.1097/HEP.0000000000001058.
9
Joint association of sleep quality and physical activity with metabolic dysfunction-associated fatty liver disease: a population-based cross-sectional study in Western China.睡眠质量和身体活动与代谢功能障碍相关脂肪性肝病的联合关联:中国西部一项基于人群的横断面研究。
Nutr Diabetes. 2024 Jul 22;14(1):54. doi: 10.1038/s41387-024-00312-3.
10
Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢相关脂肪性肝病相关肝细胞癌。
JAMA Netw Open. 2024 Jul 1;7(7):e2421019. doi: 10.1001/jamanetworkopen.2024.21019.